New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Alymsys bevacizumab-maly Click here for more information |
Amneal Pharm. | A new biosimilar to Avastin. |
|
Amvuttra vutrisiran Click here for more information |
Alnylam | A double-stranded siRNA-GaINAc conjugate for polyneuropathy of hereditary transthyretin-mediated amyloidosis. |
|
Camzyos mavacamten Click here for more information |
Bristol-Myers Squibb | A cardiac myosin inhibitor for obstructive hypertrophic cardiomyopathy. |
|
Cibinqo abrocitinib Click here for more information |
Pfizer | A Janus kinase inhibitor for refractory, moderate to severe atopic dermatitis. |
|
Enjaymo sutimlimab-jome Click here for more information |
Bioverativ USA | A monoclonal antibody for patients with cold agglutinin disease. |
|
Fylnetra Pegfilgrastim-pbbk Click here for more information. |
Amneal Pharm. | A new biosimilar to Neulasta. |
|
Kimmtrak tebentafusp-tebn Click here for more information |
Immunocore | A CD3 T cell engager for advanced uveal melanoma. |
|
Mounjaro tirzepatide Click here for more information. |
Eli Lilly | A glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist for type 2 diabetes. |
|
Opdualag nivolumab/relatlimab-rmbw Click here for more information |
Bristol-Myers Squibb | A combination monoclonal antibody for unresectable or metastatic melanoma. |
|
Pluvicto lutetium Lu 177 vipivotide tetraxetan Click here for more information |
Novartis | A radioligand agent for advanced prostate cancer. |
|
Priorix measles, mumps, and rubella vaccine |
GlaxoSmithKline | A new live vaccine to prevent measles, mumps, and rubella. |
|
Pyrukynd mitapivat Click here for more information |
Agios Pharm. | A pyruvate kinase activator for hemolytic anemia in adults with pyruvate kinase deficiency. |
|
Quviviq daridorexant Click here for more information |
Idorsia Pharm. | An orexin receptor antagonist for insomnia. |
|
Releuko filgrastim-ayow Click here for more information |
Amneal Biosciences | A biosimilar to Neupogen. |
|
SpikeVax Covid-19 vaccine, mRNA |
Moderna | A vaccine to prevent COVID-19 infection in patients 18 years of age and older. |
|
Tyvaso treprostinil Click here for more information. |
United Therapeutics | A prostacyclin analogue for pulmonary hypertension. |
|
Vabysmo faricimab-svoa Click here for more information |
Genentech | An intravitreal injection for age-related macular degeneration and diabetes-associated macular edema. |
|
Vivjoa oteseconazole Click here for more information |
Mycovia Pharm | An azole antifungal for vulvovaginal candidiasis. |
|
Vonjo pacritinib Click here for more information |
CTI BioPharma | A kinase inhibitor for myelofibrosis. |
|
Voquezna vonoprazan Click here for more information |
Phathom Pharma | A potassium-competitive acid blocker co-packaged with amoxicillin (Dual Pak) or amoxicillin and clarithromycin (Triple Pak) for Helicobacter pylori. |
|
Vtama tapinarof |
Dermavant Sciences | A topical steroid-free aryl hydrocarbon receptor agonist for plaque psoriasis. |
|
Ztalmy ganaxolone Click here for more information |
Marinus Pharm. | An antiseizure medication for patients with cyclin-dependent kinase-like 5 deficiency disorder. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Adlarity donepezil Click here for more information |
Corium | New transdermal patch formulation for Alzheimer’s dementia. |
|
Aspruzyo Sprinkle ranolazine Click here for more information |
Sun Pharm. | New extended-release granule formulation for chronic angina. |
|
Dapzura RT daptomycin Click here for more information |
Baxter Healthcare | New formulation injectable antibiotic. |
|
Drospirenone drospirenone Click here for more information |
Exeltis USA | New chewable tablet progestin-only oral contraceptive. |
|
Epsolay benzoyl peroxide Click here for more information |
Sol-Gel Technologies | New topical cream formulation for rosacea. |
|
Fleqsuvy baclofen Click here for more information |
Azurity Pharm. | A new oral suspension formulation for spasticity due to multiple sclerosis and spinal cord injuries. |
|
Hyftor sirolimus Click here for more information |
Nobelpharma America | A new topical gel formulation for facial angiofibroma. |
|
Igalmi dexmedetomidine Click here for more information |
BioXcel Therapeutics | A new sublingual film formulation for acute agitation associated with schizophrenia or bipolar I or II disorder. |
|
Norliqva amlodipine Click here for more information |
CMP Pharma | New oral solution formulation calcium channel blocker. |
|
Radicava ORS edaravone Click here for more information. |
Mitsubishi Tanabe Pharma America | New oral suspension formulation for amyotrophic lateral sclerosis (also known as Lou Gehrig’s disease). |
|
Ryaltris olopatadine/ mometasone Click here for more information |
Hikma Specialty | New nasal spray formulation combining an antihistamine and corticosteroid for seasonal allergic rhinitis. |
|
Tadliq tadalafil Click here for more information |
CMP Development | New oral suspension formulation for pulmonary hypertension. |
|
Tlando testosterone undecanoate Click here for more information |
Antares | New lower-strength capsules for testosterone replacement therapy. |
|
Tpoxx tecovirimat Click here for more information. |
SIGA Technologies | New formulation injectable treatment for smallpox disease. |
|
Vijoice alpelisib Click here for more information |
Novartis | New kinase inhibitor formulation for PIK3CA-Related Overgrowth Spectrum. |
|
Xelstrym dextroamphetamine Click here for more information |
Noven Therapeutics | New transdermal patch formulation for ADHD. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Ukoniq umbralisib Click here for more information. |
TG Therapeutics | Withdrawn due to possible increased risk of death. |
|
Zelnorm tegaserod Click here for more information |
Alfasigma | Withdrawn for business reasons, not due to safety or efficacy concerns. |